Mitsubishi Chemical to Fix “Overextension” of Pharma Biz, Focus on 4 Therapeutic Areas, Japan/US: CEO

February 28, 2023
Mitsubishi Chemical Group President and CEO Jean-Marc Gilson Mitsubishi Chemical Group is set to restructure its pharmaceutical business by retreating from an “overextension” in non-core fields and zeroing in on four therapeutic areas and two markets, Japan and the US,...read more